Verona Pharma plc - SPONSORED ADS (VRNA)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADS
Shares, excl. options Q1 2024
66.2 M
Holdings value Q1 2024
$1.07 B
Value change Q1 2024
-$19.2 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
106
Number of buys Q1 2024
54
Number of sells Q1 2024
-44
Average buys Q1 2024 %
+0.003%
Average sells Q1 2024 %
-0.001%
CUSIP
925050106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 66.2 M $1.07 B -$19.2 M $16.09 106
2023 Q4 66.6 M $1.33 B +$7.18 M $19.88 111
2023 Q3 64.9 M $1.07 B +$34.8 M $16.30 96
2023 Q2 62.5 M $1.33 B +$49.5 M $21.14 99
2023 Q1 60.3 M $1.21 B +$167 M $20.08 90
2022 Q4 50.1 M $1.31 B +$110 M $26.13 86
2022 Q3 51.8 M $529 M +$183 M $10.22 66
2022 Q2 34.8 M $146 M -$8.61 M $4.19 36
2022 Q1 36.4 M $182 M -$2.54 M $4.99 38
2021 Q4 36.9 M $248 M +$379 K $6.72 40
2021 Q3 37 M $203 M +$753 K $5.48 38
2021 Q2 36.7 M $240 M +$947 K $6.54 35
2021 Q1 36.5 M $305 M +$6.93 M $8.36 37
2020 Q4 35.7 M $246 M +$8.1 M $7.00 34
2020 Q3 34.1 M $213 M +$168 M $6.24 27
2020 Q2 7.17 M $33.6 M +$912 K $4.68 18
2020 Q1 6.98 M $28.8 M +$4.64 M $4.12 14
2019 Q4 5.85 M $33.7 M +$46.4 K $5.75 13
2019 Q3 5.86 M $26.8 M -$7.63 M $4.57 12
2019 Q2 7.37 M $37.6 M -$77.8 K $5.10 16
2019 Q1 7.38 M $47.5 M -$1.63 M $6.50 17
2018 Q4 8.41 M $78.6 M -$2.82 M $9.05 17
2018 Q3 7.38 M $92.3 M +$11 M $12.51 14
2018 Q2 5 M $68.3 M -$1.25 M $13.66 12
2018 Q1 6.58 M $132 M -$1.92 M $20.00 14
2017 Q4 6.68 M $79.3 M +$6.21 M $11.87 10
2017 Q3 5.28 M $81 M +$20.7 M $15.35 9
2017 Q2 3.95 M $46.1 M +$46.1 M $11.66 9